- Home
- News
- latamerica
- coronavirus testing
Coronavirus Testing Articles & Analysis
12 news found
Today, the Baker-Polito Administration announced that more than $1.5 million has been awarded to four projects that seek to increase testing capacity and provide solutions for coronavirus testing. The funding is through the Accelerating Coronavirus Testing Solutions (A.C.T.S.) ...
Now with this timely expansion to our study population, we can help more people and test NBT- NM108’s efficacy not just for diabetic patients, but for anyone with COVID-19 symptoms,” said Jeffrey Zhao, Co-founder and CEO at Notitia. ...
While the treatment, NBT-NM108, does not target the coronavirus directly, it does help to create stable foundation for a healthy digestive tract. ...
The first section of the Advisory addresses “Products claiming to be effective against the coronavirus causing COVID-19.” That title has changed, as well as the language throughout the Advisory, to refer now to products that are “effective against” the coronavirus, instead of products that “kill” the ...
The test arrived in the mail in early November. I took it on a Wednesday, then mailed off my sample to Vienna for processing. ...
If some of the many thousands of human volunteers needed to test coronavirus vaccines could have been replaced by digital replicas—one of this year’s Top 10 Emerging Technologies—COVID-19 vaccines might have been developed even faster, saving untold lives. Soon virtual clinical trials could be a reality for testing new ...
(NYSE: TMO), the world leader in serving science, today introduced two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. ...
Israeli blood testing startup S.D. Sight Diagnostics Ltd. has raised $71 million from international venture capital funds and U.S. corporations, Clal Biotechnology Industries Ltd. revealed in a report sent to the Tel Aviv Stock Exchange last week. ...
Environmental Protection Agency’s (EPA) Office of Enforcement and Compliance Assurance (OECA) announced that it issued a compliance advisory on products claiming to kill SARS-CoV-2, the novel coronavirus that causes COVID-19. EPA states that the advisory was issued because it has received tips and complaints concerning potentially false or misleading claims, including ...
OVM will synthesise, develop the manufacturing process and do preclinical testing before partnering to scale up manufacturing and clinical testing. ...
Millions of people have been tested for the novel coronavirus, most using a kit that relies on the polymerase chain reaction (PCR). ...
70+ StartX Med Innovators with Medical Breakthroughs for the Prevention, Diagnostics and Treatment of Coronavirus Mobilize Efforts to Fast-Track Public Health Needs During Pandemic. ...